EZH2 and matrix co-regulate phenotype and KCNB2 expression in bladder smooth muscle cells

Area of Science:

• Urology
• Epigenetics
• Molecular Biology

Background:

• Partial bladder outlet obstruction (PBO) causes urinary dysfunction and significant healthcare costs.
• Previous studies linked obstruction to altered epigenetic regulation and cell function.
• This study investigates epigenetic changes in PBO and chronic bladder obstructive disease (COBD).

Purpose of the Study:

• To examine if PBO and COBD affect epigenetic marks in a proof-of-principle gene.
• To explore mechanisms of epigenetic regulation in bladder smooth muscle cells (SMC).

Main Methods:

• Rats underwent surgical ligation to model PBO and COBD, with sham ligations as controls.
• Histone3 lysine27 trimethylation (H3K27me3) was assessed using immunostaining and ChIP/PCR.
• In vitro studies used human bladder SMCs on different matrices, treated with EZH2 inhibitor (UNC1999), and analyzed for KCNB2, H3K27me3, and cell phenotype.

Main Results:

• H3K27me3 levels increased in the KCNB2 promoter region during PBO and COBD.
• Obstruction led to increased H3K27me3 deposition compared to sham procedures.
• In vitro, EZH2 inhibition restored KCNB2 expression and partially normalized SMC phenotype.

Conclusions:

• KCNB2 gene regulation shows dynamic H3K27me3 changes during obstruction.
• In vitro models suggest matrix interactions influence EZH2, H3K27me3, and KCNB2 regulation.
• These epigenetic mechanisms may control smooth muscle cell phenotype in vivo.